Cargando…
Recommendations for clinical monitoring of patients with acid sphingomyelinase deficiency (ASMD)
BACKGROUND: Acid sphingomyelinase deficiency (ASMD), a rare lysosomal storage disease, results from mutations in SMPD1, the gene encoding acid sphingomyelinase (ASM). As a result, sphingomyelin accumulates in multiple organs including spleen, liver, lung, bone marrow, lymph nodes, and in the most se...
Autores principales: | Wasserstein, Melissa, Dionisi-Vici, Carlo, Giugliani, Roberto, Hwu, Wuh-Liang, Lidove, Olivier, Lukacs, Zoltan, Mengel, Eugen, Mistry, Pramod K., Schuchman, Edward H., McGovern, Margaret |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7249497/ https://www.ncbi.nlm.nih.gov/pubmed/30514648 http://dx.doi.org/10.1016/j.ymgme.2018.11.014 |
Ejemplares similares
-
Consensus recommendation for a diagnostic guideline for acid sphingomyelinase deficiency
por: McGovern, Margaret M., et al.
Publicado: (2017) -
Disease manifestations and burden of illness in patients with acid sphingomyelinase deficiency (ASMD)
por: McGovern, Margaret M., et al.
Publicado: (2017) -
Prospective study of the natural history of chronic acid sphingomyelinase deficiency in children and adults: eleven years of observation
por: McGovern, Margaret M., et al.
Publicado: (2021) -
Olipudase alfa for treatment of acid sphingomyelinase deficiency (ASMD): safety and efficacy in adults treated for 30 months
por: Wasserstein, Melissa P., et al.
Publicado: (2018) -
Consensus clinical management guidelines for acid sphingomyelinase deficiency (Niemann–Pick disease types A, B and A/B)
por: Geberhiwot, Tarekegn, et al.
Publicado: (2023)